Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check6 days agoChange DetectedEnrollment is now closed to new participants, and the history shows a new revision (v3.6.0) was added while the previous revision (v3.5.5) was removed.SummaryDifference0.2%

- Check13 days agoChange DetectedA new revision entry (v3.5.5) was added to the history, updating the record's version list. The previous revision (v3.5.4) was removed from the history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now shows a new revision entry v3.5.4 and removes v3.5.3 from the list. This reflects an internal update to the page's versioning.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s interface/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a maintenance or UI release rather than a change to the trial record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.2 was added to the history. Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check77 days agoChange DetectedNew results have been posted, and the Outcomes Measures, Results, and Study Status sections have been updated.SummaryDifference0.4%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.